Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Feb 1;159(2):463–478. doi: 10.1084/jem.159.2.463

Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages

PMCID: PMC2187220  PMID: 6607315

Abstract

Spleen cells of diabetes-prone BB Wistar rats were found to generate excessively low proliferative responses, and interleukin 2 (IL-2) levels in response to T-dependent mitogens. This abnormality was not due solely to abnormal T cell numbers since: (a) addition of BB spleen cells of BB splenic macrophages to normal major histocompatibility complex (MHC)-matched Wistar Furth (WF) spleen cells resulted in severe suppression of concanavalin A (Con A)-, phytohemagglutinin (PHA)-, and pokeweed mitogen (PWM)-mediated proliferation, and IL-2 production; (b) macrophage depletion from BB spleen cells, but not B cell or T cell depletion, removed completely the suppressive effects of BB cells on WF cells; (c) macrophage depletion greatly enhanced the response of BB lymphocytes to T-dependent mitogens. Although suppressor macrophages could also be found in the spleen of WF control rats they were present in much smaller numbers than in the spleen of BB rats. The suppressive effect of BB macrophages was partially reduced by addition of the prostaglandin synthetase inhibitor indomethacin to cultures. Furthermore, indomethacin (but not catalase or PMA) considerably augmented IL-2 secretion of Con A-stimulated BB spleen cells, but had little effect on WF spleen cells. In contrast, prostaglandins E1 and E2 (PGE1 and PGE2) suppressed IL-2 production. While IL-2 secretion was severely depressed in BB rats unstimulated and lipopolysaccharide (LPS)- stimulated IL-1 secretion by splenic macrophages was normal. BB macrophages did not inactivate IL-2. Low IL-2 production and macrophage- mediated suppression were features of all BB rats tested.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman A., Theofilopoulos A. N., Weiner R., Katz D. H., Dixon F. J. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med. 1981 Sep 1;154(3):791–808. doi: 10.1084/jem.154.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Basch R. S., Berman J. W., Lakow E. Cell separation using positive immunoselective techniques. J Immunol Methods. 1983 Feb 11;56(3):269–280. doi: 10.1016/s0022-1759(83)80016-7. [DOI] [PubMed] [Google Scholar]
  3. Bellgrau D., Naji A., Silvers W. K., Markmann J. F., Barker C. F. Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect. Diabetologia. 1982 Oct;23(4):359–364. doi: 10.1007/BF00253745. [DOI] [PubMed] [Google Scholar]
  4. Colle E., Guttmann R. D., Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med. 1981 Oct 1;154(4):1237–1242. doi: 10.1084/jem.154.4.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dauphinée M. J., Kipper S. B., Wofsy D., Talal N. Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol. 1981 Dec;127(6):2483–2487. [PubMed] [Google Scholar]
  6. Dyrberg T., Nakhooda A. F., Baekkeskov S., Lernmark A., Poussier P., Marliss E. B. Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes. 1982 Mar;31(3):278–281. doi: 10.2337/diab.31.3.278. [DOI] [PubMed] [Google Scholar]
  7. Elder M. E., Maclaren N. K. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol. 1983 Apr;130(4):1723–1731. [PubMed] [Google Scholar]
  8. Elder M., Maclaren N., Riley W., McConnell T. Gastric parietal cell and other autoantibodies in the BB rat. Diabetes. 1982 Apr;31(4 Pt 1):313–318. doi: 10.2337/diab.31.4.313. [DOI] [PubMed] [Google Scholar]
  9. Gershwin M. E., Castles J. J., Saito W., Ahmed A. Studies of congenitally immunologically mutant New Zealand mice. VII: the ontogeny of thymic abnormalities and reconstitution of nude NZB/W mice. J Immunol. 1982 Nov;129(5):2150–2155. [PubMed] [Google Scholar]
  10. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  11. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977 Dec 1;146(6):1719–1734. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  13. Guttmann R. D., Colle E., Michel F., Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. II. T lymphopenia and its association with clinical disease and pancreatic lymphocytic infiltration. J Immunol. 1983 Apr;130(4):1732–1735. [PubMed] [Google Scholar]
  14. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J., Kuehl F. A., Jr, Davies P. Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature. 1977 Sep 8;269(5624):149–151. doi: 10.1038/269149a0. [DOI] [PubMed] [Google Scholar]
  15. Kalant N., Seemayer T. Malignant lymphoma in spontaneously diabetic rats. N Engl J Med. 1979 Mar 29;300(13):737–737. doi: 10.1056/NEJM197903293001318. [DOI] [PubMed] [Google Scholar]
  16. Kolb H., Freytag G., Kiesel U., Kolb-Bachofen V. Spontaneous autoimmune reactions against pancreatic islets in mouse strains with generalized autoimmune disease. Diabetologia. 1980 Sep;19(3):216–221. doi: 10.1007/BF00275272. [DOI] [PubMed] [Google Scholar]
  17. Like A. A., Rossini A. A., Guberski D. L., Appel M. C., Williams R. M. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science. 1979 Dec 21;206(4425):1421–1423. doi: 10.1126/science.388619. [DOI] [PubMed] [Google Scholar]
  18. Linker-Israeli M., Bakke A. C., Kitridou R. C., Gendler S., Gillis S., Horwitz D. A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 Jun;130(6):2651–2655. [PubMed] [Google Scholar]
  19. Ly I. A., Mishell R. I. Separation of mouse spleen cells by passage through columns of sephadex G-10. J Immunol Methods. 1974 Aug;5(3):239–247. doi: 10.1016/0022-1759(74)90108-2. [DOI] [PubMed] [Google Scholar]
  20. Markenson J. A., Lockshin M. D., Fuzesi L., Warburg M., Joachim C., Morgan J. W. Supressor monocytes in patients with systemic lupus erythematosus. Evidence of suppressor activity associated with a cell-free soluble product of monocytes. J Lab Clin Med. 1980 Jan;95(1):40–48. [PubMed] [Google Scholar]
  21. Markenson J. A., Morgan J. W., Lockshin M. D., Joachim C., Winfield J. B. Responses of fractionated cells from patients with systemic lupus erythematosus and normals to plant mitogen: evidence for a suppressor population of monocytes. Proc Soc Exp Biol Med. 1978 May;158(1):5–9. doi: 10.3181/00379727-158-40127. [DOI] [PubMed] [Google Scholar]
  22. Marliss E. B., Nakhooda A. F., Poussier P., Sima A. A. The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia. 1982 Apr;22(4):225–232. doi: 10.1007/BF00281296. [DOI] [PubMed] [Google Scholar]
  23. Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol. 1980 Feb;124(2):983–988. [PubMed] [Google Scholar]
  24. Pace J. L., Russell S. W., Torres B. A., Johnson H. M., Gray P. W. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol. 1983 May;130(5):2011–2013. [PubMed] [Google Scholar]
  25. Prud'Homme G. J., Park C. L., Fieser T. M., Kofler R., Dixon F. J., Theofilopoulos A. N. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med. 1983 Feb 1;157(2):730–742. doi: 10.1084/jem.157.2.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Prud'homme G. J., Balderas R. S., Dixon F. J., Theofilopoulos A. N. B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med. 1983 Jun 1;157(6):1815–1827. doi: 10.1084/jem.157.6.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rappaport R. S., Dodge G. R. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med. 1982 Mar 1;155(3):943–948. doi: 10.1084/jem.155.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rosenstreich D. L., Mizel S. B. Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate. J Immunol. 1979 Oct;123(4):1749–1754. [PubMed] [Google Scholar]
  29. Rossini A. A., Mordes J. P., Pelletier A. M., Like A. A. Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat. Science. 1983 Feb 25;219(4587):975–977. doi: 10.1126/science.6823559. [DOI] [PubMed] [Google Scholar]
  30. Santoro T. J., Luger T. A., Ravache E. S., Smolen J. S., Oppenheim J. J., Steinberg A. D. In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol. 1983 Jul;13(7):601–604. doi: 10.1002/eji.1830130717. [DOI] [PubMed] [Google Scholar]
  31. Schreiber R. D., Pace J. L., Russell S. W., Altman A., Katz D. H. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J Immunol. 1983 Aug;131(2):826–832. [PubMed] [Google Scholar]
  32. Seemayer T. A., Oligny L. L., Tannenbaum G. S., Goldman H., Colle E. Animal model of human disease. Diabetes mellitus. Am J Pathol. 1980 Nov;101(2):485–488. [PMC free article] [PubMed] [Google Scholar]
  33. Seemayer T. A., Schürch W., Kalant N. B cell lymphoproliferation in spontaneously diabetic BB Wistar rats. Diabetologia. 1982 Sep;23(3):261–265. doi: 10.1007/BF00252852. [DOI] [PubMed] [Google Scholar]
  34. Seemayer T. A., Tannenbaum G. S., Goldman H., Colle E. Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light-microscopic and ultrastructural observations of pancreatic islets of Langerhans. Am J Pathol. 1982 Feb;106(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  35. Steinberg A. D., Huston D. P., Taurog J. D., Cowdery J. S., Ravecheé E. S. The cellular and genetic basis of murine lupus. Immunol Rev. 1981;55:121–154. doi: 10.1111/j.1600-065x.1981.tb00341.x. [DOI] [PubMed] [Google Scholar]
  36. Sternthal E., Like A. A., Sarantis K., Braverman L. E. Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes. 1981 Dec;30(12):1058–1061. doi: 10.2337/diab.30.12.1058. [DOI] [PubMed] [Google Scholar]
  37. Theofilopoulos A. N., Dixon F. J. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55:179–216. doi: 10.1111/j.1600-065x.1981.tb00343.x. [DOI] [PubMed] [Google Scholar]
  38. Wysocki L. J., Sato V. L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844–2848. doi: 10.1073/pnas.75.6.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yoon J. W., Melez K. A., Smathers P. A., Archer J. A., Steinberg A. D. Virus-induced diabetes in autoimmune New Zealand mice. Diabetes. 1983 Aug;32(8):755–759. doi: 10.2337/diab.32.8.755. [DOI] [PubMed] [Google Scholar]
  40. Zembala M., Lemmel E. M. Inhibitory factor(s) of lymphoproliferation produced by synovial fluid mononuclear cells from rheumatoid arthritis patients: the role of monocytes in suppression. J Immunol. 1980 Sep;125(3):1087–1092. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES